维普中文期刊产品整合服务
76篇 您的检索式:作者名="THIERRY POYNARD"
    题名 作者 年代 出处 被引量
1Applicability and variability of liver stiffness measurements according to probe position显示文摘AIM: To investigate the liver stiffness measurement (LSM) applicability and variability with reference to three probe positions according to the region of liver biopsy. METHODS: The applicability for LSM was defined as at least 10 valid measurements with a success rate greater than 60% and an interquartile range/median LSM < 30%. The LSM variability compared the inter-position concordance and the concordance with FibroTest. RESULTS: Four hundred and forty two consecutive patients were included. The applicability of the anterior position (81%) was significantly higher than that of the reference (69%) and lower positions (68%), (both P = 0.0001). There was a signif icant difference (0.5 kPa, 95% CI 0.13-0.89; P < 0.0001) between mean LSM estimated at the reference position (9.3 kPa) vs the anterior position (8.8 kPa). Discordance between positions was associated with thoracic fold (P = 0.008). The discordance rate between the reference position result and FibroTest was higher when the 7.1 kPa cutoff was used to define advanced fibrosis instead of 8.8 kPa (33.6% vs 23.5%, P = 0.03).CONCLUSION: The anterior position of the probe should be the fi rst choice for LSM using Fibroscan, as it has a higher applicability without higher variability compared to the usual liver biopsy position.Patrick Ingiliz Kim Pav Chhay Mona Munteanu Pascal Lebray Yen Ngo Dominique Roulot Yves Benhamou Dominique Thabut Vlad Ratziu Thierry Poynard 2009World Journal of Gastroenterology2009,15,27:5
2Aging of Hepatitis C Virus (HCV)-Infected Persons in the United States: A Multiple Cohort Model of HCV Prevalence and Disease Progression显示文摘Gary L. Davis Miriam J. Alter Hashem El–Serag Thierry Poynard Linda W. Jennings 2010Gastroenterology2010,,2:5
3Factors That Predict Response of Patients With Hepatitis C Virus Infection to Boceprevir显示文摘Fred Poordad Jean–Pierre Bronowicki Stuart C. Gordon Stefan Zeuzem Ira M. Jacobson Mark S. Sulkowski Thierry Poynard Timothy R. Morgan Cliona Molony Lisa D. Pedicone Heather L. Sings Margaret H. Burroughs Vilma Sniukiene Navdeep Boparai Venkata S. Goteti 2012Gastroenterology2012,,3:5
4Sampling Variability of Liver Biopsy in Nonalcoholic Fatty Liver Disease显示文摘Vlad Ratziu Frédéric Charlotte Agnès Heurtier Sophie Gombert Philippe Giral Eric Bruckert André Grimaldi Frédérique Capron Thierry Poynard 2005Gastroenterology2005,,7:4
5Natural history of liver fibrosis progression in patients with chronic hepatitis C显示文摘Thierry Poynard Pierre Bedossa Pierre Opolon 1997The Lancet . 1997 (9055)1997,,:3
6Triple therapy in treatment-experienced patients with HCV-cirrhosis in a multicentre cohort of the French Early Access Programme (ANRS CO20-CUPIC) – NCT01514890<!-- Doctopic: VH -->显示文摘Christophe Hézode Hélène Fontaine Céline Dorival Dominique Larrey Fabien Zoulim Valérie Canva Victor de Ledinghen Thierry Poynard Didier Samuel Marc Bourlière Jean-Pierre Zarski Jean-Jacques Raabe Laurent Alric Patrick Marcellin Ghassan Riachi Pierre-Henr 2013Journal of Hepatology2013,,:2
7A systematic review of follow-up biopsies reveals disease progression in patients with non-alcoholic fatty liver显示文摘Raluca Pais Fréderic Charlotte Larissa Fedchuk Pierre Bedossa Pascal Lebray Thierry Poynard Vlad Ratziu 2013Journal of Hepatology2013,,:2
8Low 25-OH vitamin D serum levels correlate with severe fibrosis in HIV-HCV co-infected patients with chronic hepatitis显示文摘Benjamin Terrier Fabrice Carrat Guillaume Geri Stanislas Pol Lionel Piroth Philippe Halfon Thierry Poynard Jean-Claude Souberbielle Patrice Cacoub 2011Journal of Hepatology2011,,4:2
9Factors That Predict Response of Patients With Hepatitis C Virus Infection to Boceprevir显示文摘Fred Poordad Jean–Pierre Bronowicki Stuart C. Gordon Stefan Zeuzem Ira M. Jacobson Mark S. Sulkowski Thierry Poynard Timothy R. Morgan Cliona Molony Lisa D. Pedicone Heather L. Sings Margaret H. Burroughs Vilma Sniukiene Navdeep Boparai Venkata S. Goteti 2012Gastroenterology2012,,3:2
10Liver fibrosis evaluation using real-time shear wave elastography: Applicability and diagnostic performance using methods without a gold standard显示文摘Thierry Poynard Mona Munteanu Elena Luckina Hugo Perazzo Yen Ngo Luca Royer Larysa Fedchuk Florence Sattonnet Raluca Pais Pascal Lebray Marika Rudler Dominique Thabut Vlad Ratziu 2013Journal of Hepatology2013,,5:2
11Chronic hepatitis C virus (HCV) disease burden and cost in the United States显示文摘Homie Razavi Antoine C. ElKhoury Elamin Elbasha Chris Estes Ken Pasini Thierry Poynard Ritesh Kumar 2013Hepatology2013,,6:2
12A systematic review of follow-up biopsies reveals disease progression in patients with non-alcoholic fatty liver<!-- Doctopic: GMD -->显示文摘Raluca Pais Fréderic Charlotte Larissa Fedchuk Pierre Bedossa Pascal Lebray Thierry Poynard Vlad Ratziu 2013Journal of Hepatology2013,,:2
13Adherence to combination therapy enhances sustained response in genotype-1–infected patients with chronic hepatitis C显示文摘John G. McHutchison Michael Manns Keyur Patel Thierry Poynard Karen L. Lindsay Christian Trepo Jules Dienstag William M. Lee Carmen Mak Jean–Jacques Garaud Janice K. Albrecht 2002Gastroenterology2002,,4:2
14Staging chronic hepatitis C in seven categories using fibrosis biomarker (FibroTest?) and transient elastography (FibroScan?)显示文摘Thierry Poynard Julien Vergniol Yen Ngo Juliette Foucher Mona Munteanu Wassil Merrouche Massimo Colombo Vincent Thibault Eugene Schiff Clifford A. Brass Janice K. Albrecht Marika Rudler Olivier Deckmyn Pascal Lebray Dominique Thabut Vlad Ratziu Victor de 2013Journal of Hepatology2013,,:2
15Viral hepatitis B显示文摘Ching Lung Lai Vlad Ratziu Man-Fung Yuen Thierry Poynard 2003The Lancet2003,,9401:2
16Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis C显示文摘Thierry Poynard Vlad Ratziu Frédéric Charlotte Zachary Goodman John McHutchison Janice Albrecht 2001Journal of Hepatology2001,,:1
17Alpha-2-macroglobulin and hepatic fibrosis显示文摘Dr. Sylvie Naveau MD Thierry Poynard Clarisse Benattar Pierre Bedossa Jean-Claude Chaput 1994Digestive Diseases and Sciences1994,,11:1
18Viral hepatitis C显示文摘Thierry Poynard Man-Fung Yuen Vlad Ratzin Ching Lung Lai 2003The Lancet2003,,9401:1
19Rosiglitazone for Nonalcoholic Steatohepatitis: One-Year Results of the Randomized Placebo-Controlled Fatty Liver Improvement With Rosiglitazone Therapy (FLIRT) Trial显示文摘Vlad Ratziu Philippe Giral Sophie Jacqueminet Fréderic Charlotte Agnès Hartemann–Heurtier Lawrence Serfaty Philippe Podevin Jean–Marc Lacorte Carole Bernhardt Eric Bruckert André Grimaldi Thierry Poynard 2008Gastroenterology2008,,1:1
20Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study显示文摘Fran?oise Imbert-Bismut Vlad Ratziu Laurence Pieroni Frederic Charlotte Yves Benhamou Thierry Poynard 2001The Lancet2001,,9262:1
返回顶部 每页显示:
共4页 首页 上一页 第1页 下一页 末页 /4 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费